In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.
Updated: 2seventy lays off 40% of staff, prunes CAR-T pipeline as Nick Leschly steps down as CEO
With an early-stage CAR-T under clinical hold, 2seventy bio is slashing its headcount by 40% and capping spending on some pipeline programs to focus on
September 13, 2023